3.500USD-6.67%Mkt Cap: 14.03M USDP/E: —Last update: 2026-05-26
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap14.03M USD
Enterprise Value6.81M USD
Revenue (TTM)1.44M USD
Gross Profit1.18M USD
Net Income (TTM)-12.15M USD
Revenue/Share0.5060 USD
Last Price3.500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.54
PEG—
EV/EBITDA—
EV/Revenue4.74
P/S11.02
P/B2.16
EPS (TTM)-2.38
EPS (Forward)-2.57
52W Range
2.07013% of range13.10
52W High13.10 USD
52W Low2.070 USD
Profitability
Gross Margin95.71%
Oper. Margin-727.88%
EBITDA Margin0.00%
Profit Margin-984.60%
ROE-116.65%
ROA-85.82%
Growth
Revenue Growth68.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.60M USD
CapEx (TTM)—
FCF Margin-663.91%
FCF Yield-67.95%
Net Debt-9.02M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio2.73
Quick Ratio2.41
Book Value/Sh1.832 USD
Cash/Share2.339 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJan 5, 2026
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)10.00 USD
Target Range8.000 USD – 12.00 USD
# Analysts2
Ownership
Shares Out.4.00M
Float3.95M
Insiders0.99%
Institutions7.66%
Short Interest
Short Ratio1.0d
Short % Float5.48%
Short % Out.5.45%
Shares Short217.78K
Short (prev mo.)215.21K
Technical
SMA 503.762 (-7.0%)
SMA 2004.573 (-23.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)86.08K
Avg Vol (10d)67.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—